Yahoo! Video requires a more recent version of the Adobe Flash Player.
From
Published 56 days ago
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent System, the Company’s third-generation drug-eluting stent (DES) technology. The PROMUS Element system... more
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent System, the Company’s third-generation drug-eluting stent (DES) technology. The PROMUS Element system incorporates a unique platinum chromium alloy with an innovative stent design and an advanced catheter delivery system. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bostonscientific/36501/ « less
Tell us what you think about Yahoo! Video - Send us your feedback
Copyright © 2009 Yahoo! Inc. All rights reserved.
Comments (0)
LOADING
Add a new comment
Your reply